About this role
The Senior Manager, Market Development EMEAI – Human Disease is responsible for driving commercial growth by expanding the total addressable oncology market for Oxford Nanopore Technologies across the EMEAI region. This role focuses on identifying and unlocking new customer segments, applications, and geographies, translating ONT’s unique sequencing capabilities into scalable, commercially impactful market opportunities. Working at the intersection of science, policy, and commercial strategy, this role partners closely with sales, marketing, product, medical, regulatory, and government affairs teams to accelerate adoption and long‑term revenue growth.
This role has a primary focus on high-value applications in Human Disease and where Oxford Nanopore Technologies offers clear differentiation. The role will identify and validate priority market opportunities, develop strategic partnerships and evidence-generation programs, and support the progression of promising applications.